Veranex Appoints Manasi Ramanna as Chief Financial Officer

RALEIGH, N.C. - [August 31, 2026] - Veranex, the industry's first Innovation CRO (iCRO) redefining end-to-end MedTech development, today announced the appointment of Manasi Ramanna, MS, MBA, as Chief Financial Officer. The appointment reflects Veranex's continued investment in strengthening its executive leadership team and building the operational and financial capabilities needed to support the company's continued global growth.

Ramanna brings more than 25 years of global leadership experience spanning finance, corporate strategy, operations, and business transformation. Throughout her career, she has partnered with executive teams and boards to scale organizations, improve operational performance, lead capital raises and M&A initiatives, and build high-performing finance organizations across public companies, private equity-backed businesses, and growth-stage life sciences organizations.

Strengthening the Foundation for Growth

As Chief Financial Officer, Ramanna will lead Veranex's global finance organization, overseeing financial strategy, planning, accounting, and business performance while partnering with leaders across the company to support sustainable growth and long-term value creation.

Prior to joining Veranex, Ramanna served as founder of Edge Strategic Planning, where she advised venture-backed, family-owned, and middle-market companies as a fractional CFO and strategic advisor. She has also held executive leadership roles at Resolve Surgical Technologies, AgBiome, and Merz Pharma, leading finance, operations, strategic planning, and organizational transformation initiatives.

"Manasi is a proven leader with a unique ability to connect financial strategy with business execution," said Megan Osorio, Chief Executive Officer of Veranex. "Her experience guiding organizations through growth and transformation, combined with her collaborative leadership style, makes her the right person to lead our global finance organization. I'm excited to welcome her to the executive team as we continue building the future of Veranex."

Throughout her career, Ramanna has successfully led organizations through complex business transformations, capital raises, mergers and acquisitions, operational integrations, and process improvements. She is recognized for building collaborative, high-performing teams and leveraging data-driven insights to enable strategic decision-making.

"I'm excited to join Veranex as Chief Financial Officer at such an important stage in the company's journey," said Ramanna. "By combining financial discipline with actionable strategic insights, we can help the business make impactful decisions, scale effectively, and create lasting value. I'm looking forward to partnering with our teams to support innovation, strengthen our financial foundation, and help Veranex continue delivering exceptional outcomes for our clients."

About Veranex

Veranex is a global, fully integrated Innovation CRO dedicated to accelerating MedTech innovation from early concept through commercialization. Headquartered in Raleigh, N.C., and powered by more than 800 specialists worldwide, Veranex combines design & engineering, preclinical, clinical, regulatory, manufacturing, and market access expertise to deliver clarity, confidence, and speed-turning vision into velocity for device and diagnostics innovators.

For more information, visit Veranex.com